- Home
- KALV vs CPF Comparison
KALV vs CPF Comparison
Compare KALV & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- CPF
- Stock Information
- Founded
- KALV N/A
- CPF 1954
- Country
- KALV United States
- CPF United States
- Employees
- KALV N/A
- CPF N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- CPF Major Banks
- Sector
- KALV Health Care
- CPF Finance
- Exchange
- KALV Nasdaq
- CPF Nasdaq
- Market Cap
- KALV 642.3M
- CPF 725.7M
- IPO Year
- KALV N/A
- CPF N/A
- Fundamental
- Price
- KALV $11.25
- CPF $28.03
- Analyst Decision
- KALV Strong Buy
- CPF Buy
- Analyst Count
- KALV 8
- CPF 1
- Target Price
- KALV $24.83
- CPF $30.00
- AVG Volume (30 Days)
- KALV 1.1M
- CPF 199.8K
- Earning Date
- KALV 07-10-2025
- CPF 07-30-2025
- Dividend Yield
- KALV N/A
- CPF 3.86%
- EPS Growth
- KALV N/A
- CPF 4.40
- EPS
- KALV N/A
- CPF 2.14
- Revenue
- KALV N/A
- CPF $247,706,000.00
- Revenue This Year
- KALV N/A
- CPF $0.80
- Revenue Next Year
- KALV N/A
- CPF $6.33
- P/E Ratio
- KALV N/A
- CPF $13.06
- Revenue Growth
- KALV N/A
- CPF 5.37
- 52 Week Low
- KALV $7.30
- CPF $20.55
- 52 Week High
- KALV $15.50
- CPF $33.25
- Technical
- Relative Strength Index (RSI)
- KALV 35.75
- CPF 63.25
- Support Level
- KALV $11.10
- CPF $26.91
- Resistance Level
- KALV $12.17
- CPF $28.21
- Average True Range (ATR)
- KALV 0.86
- CPF 0.58
- MACD
- KALV -0.21
- CPF 0.16
- Stochastic Oscillator
- KALV 30.34
- CPF 92.77
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About CPF Central Pacific Financial Corp New
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.